Navigation Links
Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine
Date:12/9/2009

GAITHERSBURG, Md,, Dec. 9 /PRNewswire/ -- Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business innovation research (SBIR) grant for a program on "A Novel Method of Generating Hepatitis C Virus-Like Particles using Lentivirus". In this program, Lentigen will collaborate with Epixis SA (Paris, France).

The Hepatitis C virus is the most common blood-borne virus and HCV infection represents a major public health concern; approximately 3% of the world's population (200 million people) is chronically infected. Causing fibrosis and cirrhosis of the liver and eventually hepatocellular carcinoma, it is the leading cause of liver transplantation in the U.S. No vaccine is currently available.

Epixis SA has previously designed rVLPs pseudotyped with one or both of the HCV envelope proteins E1 and E2. Mice primed with a recombinant viral vector expressing E1 and E2 can mount unprecedented neutralizing humoral immune responses upon boosting with such pseudotyped rVLPs. Before reaching the clinic, their large scale production calls for a new efficient and safe system.

Therefore, the aim of this grant is the construction of a lentiviral vector expressing HCV rVLPs, and validation of its use for high titer production of HCV-rVLPs from human cells. This uses a similar approach to that being used in the development of a pandemic influenza VLP vaccine at Lentigen, supported by PATH.

Boro Dropulic, Lentigen's President and Chief Scientific Officer, commented, "The collaboration represents the integration of two important technologies to generate highly immunogenic HepC VLPs. The project is consistent with our strategy of applying Lentigen's technology in diseases of high unmet therapeutic need."

About Lentigen Corporation


'/>"/>
SOURCE Lentigen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
2. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
3. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
4. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
5. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
6. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
7. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
8. DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia
9. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
10. New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity
11. TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014  Australian drug delivery ... that it has raised A$19.3 million via a placement ... Europe , the U.S., Asia ... million from a share purchase plan (SPP) to be ... will be made in two tranches. "This ...
(Date:7/11/2014)... , July 11, 2014 ... to Safety & Health Expo 2014 were ... move to London , ... attending exhibition.          ... http://photos.prnewswire.com/prnh/20140711/696892-a )      (Photo: ...
(Date:7/10/2014)... 2014  Breg, Inc., a premier provider of ... FreeRunner™ knee brace with new innovations to help ... return to active lifestyles.  FreeRunner,s patent-pending design acts ... support when patients need it most, and the ... Patellofemoral issues are the most common cause ...
Breaking Medicine Technology:Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... Oct. 12 "The FDA,s just approved monthly drug treatment ... largest substance abuse treatment provider, CRC Health Group, Recovery Division ... country. Rhodes said the new treatment regimen "will provide addicts ... a new way to reduce or eliminate relapse. We are ...
... (NYSE: WPI ), a leading specialty pharmaceutical company, ... quarter 2010 financial results on Thursday, November 4, 2010 prior ... will also host a conference call and webcast at 8:30 ... its financial results and provide an update on the Company,s ...
Cached Medicine Technology:FDA's Just Approved Monthly Drug Treatment, Vivitrol Could Be 'Game Changer,' Says Country's Largest Drug Treatment Recovery President, CRC's Jerry Rhodes; Provides Addicts 'One Decision A Month Instead of 30' 2Watson to Host Conference Call and Webcast to Discuss Third Quarter 2010 Earnings 2
(Date:7/13/2014)... The North American water storage systems market ... $5,450 million by 2018, at a CAGR of 21.0%, from ... at a rapid pace in North America. The U.S. is ... water & wastewater storage and collection, and the increased spending ... expanding at a healthy rate in Canada, and is rising ...
(Date:7/13/2014)... 13, 2014 Advanced boilers are ... least amount of fossil fuels, produce high-capacity power, ... to increased global warming and climate change concerns, ... reduce harmful gas emissions and pollutants coming from ... in the global advance boilers market., The global ...
(Date:7/13/2014)... 2014 MarketsandMarkets recently conducted a ... 3D Scanning; 3D rendering; Layout and Animation; Image ... - 2018)”, which analyzes and studies the major ... Western Europe, Eastern Europe, Middle East and Africa, ... the competitive landscape of the 3D imaging market, ...
(Date:7/13/2014)... The Pearland, Texas location of The Little Gym, a gymnastics ... 12 years of age that offers everything from gymnastics, dance, ... Camps, is now under new ownership. , Kevin Berry comes ... over six years at The Little Gym of Bellaire in ... has over ten years of experience working with children, including ...
(Date:7/13/2014)... Recently, 2014QuinceaneraDresses.com, the distinguished special occasion dress manufacturer ... gorgeous Quinceanera dresses . , In ... outfits is huge. Therefore, 2014QuinceaneraDresses.com is striving to ... released dresses are made according to the latest ... , It is worthy of mention that ...
Breaking Medicine News(10 mins):Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 2Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 3Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 2Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2
... BEACH, Calif., Nov. 29 Diabetes Response,Service, the ... the United States and Canada December 1st, 2007 ... who monitor the subscribers to,prevent hypoglycemia and complications ... Diabetes Response Service provides customizable,scheduled text message reminders ...
... the More You Care About AIDS, World Vision ... ,Put a Face on the Pandemic, UNITED NATIONS, ... discovered, one-third of the people in seven wealthy nations,admit ... and AIDS epidemic,and one-fourth believe the problem is "greatly ...
... the female hormone , THURSDAY, Nov. 29 (HealthDay News) ... often given with estrogen in hormone replacement therapy -- ... say. , They conducted tests on female mice genetically ... this conclusion. , Treatment with estrogen blocked the Alzheimer,s-like ...
... Consortium Health to Create New, Database File Storage ... CAMPBELL, Calif., Nov. 29 ONStor Inc., the ... enterprise, today,announced that Consortium Health Plans, Inc., a ... Shield Plans, has chosen the ONStor,Bobcat Series NAS ...
... Administration (FDA) has accepted for filing the New, Drug ... therapy in the treatment of partial ... 29 UCB announced today that the U.S. Food,and ... Application,(NDA) for the use of lacosamide as adjunctive therapy ...
... Medco Health,Solutions, Inc. (NYSE: MHS ) today announced ... The stock split, effected in the form,of a dividend, will ... Jan. 10, 2008 to receive one additional share of Medco ... dividend will be,distributed on Jan. 24, 2008., Since becoming ...
Cached Medicine News:Health News:Diabetes Response Service Launches in U.S. and Canada 2Health News:AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic 2Health News:AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic 3Health News:AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic 4Health News:Progesterone Won't Shield Women Against Alzheimer's 2Health News:Consortium Health Plans Cuts Down on Power Usage and Cooling in Its Data Center Using ONStor's Green Clustered NAS Solution 2Health News:Consortium Health Plans Cuts Down on Power Usage and Cooling in Its Data Center Using ONStor's Green Clustered NAS Solution 3Health News:UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy 2Health News:UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy 3Health News:Medco Announces Two-For-One Stock Split 2Health News:Medco Announces Two-For-One Stock Split 3Health News:Medco Announces Two-For-One Stock Split 4Health News:Medco Announces Two-For-One Stock Split 5
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: